T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Sign Up to like & getrecommendations! Published in 2017 at "Nature"
DOI: 10.1038/nature22079
Abstract: Despite the success of monotherapies based on blockade of programmed cell death 1 (PD-1) in human melanoma, most patients do not experience durable clinical benefit. Pre-existing T-cell infiltration and/or the presence of PD-L1 in tumours… read more here.
Keywords: tumour burden; cell; response; cell invigoration ... See more keywords